Cite
HARVARD Citation
Vennera, M. et al. (2018). Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma. Thorax. 73 (8), pp. 782-784. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vennera, M. et al. (2018). Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma. Thorax. 73 (8), pp. 782-784. [Online].